BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 16606808)

  • 41. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
    Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.
    Roy DC; Wang TF; Lun R; Zahrai A; Mallick R; Burger D; Zitikyte G; Hawken S; Wells P
    Am J Hematol; 2024 Apr; 99(4):577-585. PubMed ID: 38291601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
    Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
    Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias.
    Villani M; Tiscia GL; Margaglione M; Colaizzo D; Fischetti L; Vergura P; Grandone E
    J Thromb Haemost; 2012 Feb; 10(2):223-8. PubMed ID: 22136658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic Testing for Thrombophilia-Related Genes: Observations of Testing Patterns for Factor V Leiden (G1691A) and Prothrombin Gene "Mutation" (G20210A).
    Favaloro EJ
    Semin Thromb Hemost; 2019 Oct; 45(7):730-742. PubMed ID: 31398733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factor V 1691 G-A (Leiden) polymorphism and cancer-related venous thromboembolism: a meta-analysis of published studies.
    Eroglu A; Sertkaya Karasoy D; Eroglu N; Akar N
    J BUON; 2008; 13(1):61-4. PubMed ID: 18404788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.
    Bucciarelli P; De Stefano V; Passamonti SM; Tormene D; Legnani C; Rossi E; Castaman G; Simioni P; Cini M; Martinelli I
    Blood; 2013 Oct; 122(15):2555-61. PubMed ID: 23913469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thromboembolism in heart transplantation: role of prothrombin G20210A and factor V Leiden.
    Miriuka SG; Langman LJ; Evrovski J; Miner SE; Kozuszko S; D'Mello N; Delgado DH; Wong BY; Ross HJ; Cole DE
    Transplantation; 2005 Sep; 80(5):590-4. PubMed ID: 16177630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additional genetic risk factors for venous thromboembolism in carriers of the factor V Leiden mutation.
    Tosetto A; Rodeghiero F; Martinelli I; De Stefano V; Missiaglia E; Chiusolo P; Mannucci PM
    Br J Haematol; 1998 Dec; 103(3):871-6. PubMed ID: 9858248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
    Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classic thrombophilic gene variants.
    Mannucci PM; Franchini M
    Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic Risk Factors in Venous Thromboembolism.
    Hotoleanu C
    Adv Exp Med Biol; 2017; 906():253-272. PubMed ID: 27638626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for inherited thrombophilia: indications and therapeutic implications.
    De Stefano V; Rossi E; Paciaroni K; Leone G
    Haematologica; 2002 Oct; 87(10):1095-108. PubMed ID: 12368166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
    Moussaoui S; Saussoy P; Ambroise J; Defour JP; Zouitene R; Sifi K; Abadi N
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):105-115. PubMed ID: 26304686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.